The death toll in this case is very misleading because we are now seeing, through widespread antibody testing, that orders of magnitude more people have gotten it while showing no symptoms/low symptoms, etc. This translates to a fatality rate on par with/less than the seasonal flu.
Obviously I'm not a doctor, but from the data I've seen the key differences between this and most flus are a sharp inflection in IFR (two orders of magnitude or more) somewhere around age 50, and an R0 of roughly 5-7. So even for younger populations for whom the fatality rate isn't significantly different from typical seasonal flus, many times more people could be expected to become infected.
My main concern would be those who get it (and survive) and show medium to severe symptoms while they have it as well as lingering effects we don’t know about yet.
Obviously many, many more people will be getting it and:
a.) be asymptomatic or very mild cases;
b.) be medium to severe cases and recover;
c.) be severe cases and ultimately fatalities;
It stands to reason the large majority of people will be a.).
c.) is terrible no matter what illness it is.
b.) is where the jury is still out for me. We don’t know yet what kind of lingering after effects recovering patients might exhibit.
I’ll continue to stay home and practice distancing when I do have to go out because I’d rather be cautious and find out there are no lingering effects than be in situation b.) and realize I’ll have lingering respiratory issues.